Status: current, Primitive. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4538991000168115 | A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4539001000168115 | A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| influenza quadrivalent adjuvanted geriatric vaccine 2021 injection, 0.5 mL syringe | has intended active ingredient | True | A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted | Inferred relationship | Some | 2095179448 |
| influenza quadrivalent adjuvanted geriatric vaccine 2021 injection, 0.5 mL syringe | has Australian BoSS | True | A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted | Inferred relationship | Some | 2095179448 |
| Fluad Quad 2021 injection, 0.5 mL syringe | has Australian BoSS | True | A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted | Inferred relationship | Some | 1848090594 |
| Fluad Quad 2021 injection, 0.5 mL syringe | has intended active ingredient | True | A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted | Inferred relationship | Some | 1848090594 |
| influenza quadrivalent adjuvanted vaccine 2021 | has intended active ingredient | True | A/Hong Kong/2671/2019 (H3N2)-like virus adjuvanted | Inferred relationship | Some | 1039583627 |
This concept is not in any reference sets
FHIR